| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc. (GLUE) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. GLUE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 600.0K | $11.67M | -5,467 | |
| Other | 75.0K | $1.46M | - | |
| Other | 67.8K | $1.32M | - | |
| COO | 62.4K | $1.21M | - | |
| Other | 60.8K | $1.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Warmuth Markus | President &CEO | Sell | 5,467 | $18.92 | $103,446.57 | -0.9% | - | - | |
| Jan 7, 2026 | Warmuth Markus | President &CEO | Sell | 5,466 | $23.49 | $128,372.57 | -0.3% | -26.5% | - | |
| Jan 5, 2026 | Dunn Edmund | Principal Accounting Officer | Sell | 1,039 | $15.17 | $15,761.63 | -4.4% | +17.6% | - | |
| Jan 5, 2026 | Townson Sharon | Chief Scientific Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.4% | +17.6% | - | |
| Jan 5, 2026 | Nickson Philip | Chief Business &Legal Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.9% | +17.6% | - | |
| Jan 5, 2026 | Champoux Jennifer | Chief Operating Officer | Sell | 2,629 | $15.17 | $39,881.93 | -4.0% | +17.6% | - | |
| Jan 5, 2026 | Warmuth Markus | President &CEO | Sell | 10,135 | $15.17 | $153,747.95 | -1.6% | +17.6% | - | |
| Jan 5, 2026 | Janku Filip | Chief Medical Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.0% | +17.6% | - | |
| Jun 3, 2025 | Dunn Edmund | Principal Accounting Officer | Sell | 2,062 | $4.45 | $9,174.46 | -8.0% | +6.0% | - | |
| Mar 24, 2025 | Leo Chandra P. | Director | Buy | 10,000 | $5.84 | $58,383.00 | New | -20.4% | +152.5% |